Breaking News Instant updates and real-time market news.

VSAR

Versartis

$11.62

-0.23 (-1.94%)

09:04
10/17/16
10/17
09:04
10/17/16
09:04

Versartis initiates enrollment in Japan for Phase 3 study of somavaratan

Amunix announced that Versartis has been granted approval in Japan by the PMDA to initiate enrollment for its Phase 3 study of somavaratan in pediatric patients with growth hormone deficiency.

  • 06

    Nov

  • 29

    Nov

VSAR Versartis
$11.62

-0.23 (-1.94%)

04/07/16
NORL
04/07/16
INITIATION
Target $19
NORL
Outperform
Versartis initiated with an Outperform at Northland
Target $19.
04/08/16
SBSH
04/08/16
NO CHANGE
SBSH
Citi lays out potential targets after break of Pfizer, Allergan deal
Citi analysts Yigal Nochomovitz, Liav Abraham and Joel Beatty argue that the break of the Pfizer (PFE), Allergan (AGN) merger could accelerate smaller scale acquisitions in the Biotechnology sector. The implication that larger companies could accelerate M&A activity to bolster pipelines in lieu of the mega-merger pathway aided shares in the sector this week, the analysts contend in a research note. They now believe that Ardelyx (ARDX), Medivation (MDVN), Ophthotech (OPHT), Puma Biotechnology (PBYI), Portola Pharmaceuticals (PTLA), Ultragenyx (RARE), Relypsa (RLYP) and Versartis (VSAR) have a greater probability of being acquired in the next 12-18 months. Beside these favored names for a takeover, analyst Joel Beatty sees a greater chance of Catabasis Pharmaceuticals (CATB), Intercept Pharmaceuticals (ICPT), Novavax (NVAX) and Raptor Pharmaceuticals (RPTP) getting acquired over the next 18 months.
08/11/16
SBSH
08/11/16
NO CHANGE
Target $23
SBSH
Buy
Versartis price target raised to $23 from $17 at Citi
Citi analyst Yigal Nochomovitz raised his price target for Versartis to $23 saying the company's partnership with Teijin for commercialization of somavaratan in Japan validates the drug's clinical profile. The economics of the deal are very favorable for Versartis, Nochomovitz tells investors in a research note. He keeps a Buy rating on the shares.
10/04/16
PIPR
10/04/16
INITIATION
Target $22
PIPR
Overweight
Versartis initiated with an Overweight at Piper Jaffray
Piper Jaffray analyst Edward Tenthoff started Versartis with an Overweight rating and $22 price target. The company's long-acting recombinant Human Growth Hormone to treat growth hormone deficiency, somavaratan, has a $3B global market, the analyst estimates.

TODAY'S FREE FLY STORIES

AAPL

Apple

$150.55

-1.34 (-0.88%)

, DGX

Quest Diagnostics

$94.57

-7.54 (-7.38%)

16:23
09/25/17
09/25
16:23
09/25/17
16:23
General news
On The Fly: Top stock stories for Monday »

Stocks began the session…

AAPL

Apple

$150.55

-1.34 (-0.88%)

DGX

Quest Diagnostics

$94.57

-7.54 (-7.38%)

LH

LabCorp

$150.32

-4.75 (-3.06%)

TGT

Target

$58.55

-0.44 (-0.75%)

AIG

AIG

$61.01

0.3 (0.49%)

NAV

Navistar

$42.14

0.81 (1.96%)

VLKAY

Volkswagen

$33.96

-0.61 (-1.76%)

FINL

Finish Line

$10.49

0.76 (7.81%)

NE

Noble Corp.

$4.45

0.32 (7.75%)

CATM

Cardtronics

$26.10

-3.17 (-10.83%)

S

Sprint

$7.82

-0.7 (-8.22%)

SFTBF

SoftBank

$79.96

-2.7 (-3.27%)

TMUS

T-Mobile

$62.89

-1.17 (-1.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 27

    Sep

  • 02

    Oct

  • 22

    Oct

  • 30

    Oct

  • 30

    Nov

  • 16

    May

FN

Fabrinet

$34.78

-1.17 (-3.25%)

, SANM

Sanmina

$36.00

-1.3 (-3.49%)

16:22
09/25/17
09/25
16:22
09/25/17
16:22
Hot Stocks
Fabrinet names Seamus Grady CEO »

Fabrinet (FN) announced…

FN

Fabrinet

$34.78

-1.17 (-3.25%)

SANM

Sanmina

$36.00

-1.3 (-3.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 28

    Sep

  • 29

    Sep

  • 05

    Oct

  • 06

    Oct

  • 18

    Oct

  • 19

    Oct

SNX

Synnex

$116.50

0.4 (0.34%)

16:22
09/25/17
09/25
16:22
09/25/17
16:22
Hot Stocks
Breaking Hot Stocks news story on Synnex »

Synnex up 11% to $130.02…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 16

    Oct

  • 17

    Oct

GFN

General Finance Corp

$4.95

-0.1 (-1.98%)

16:21
09/25/17
09/25
16:21
09/25/17
16:21
Hot Stocks
General Finance Corp announces funding for certain acquisition »

General Finance announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KEX

Kirby

$64.35

0.35 (0.55%)

16:20
09/25/17
09/25
16:20
09/25/17
16:20
Hot Stocks
Breaking Hot Stocks news story on Kirby »

Hushang Ansary reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

SNWV

Sanuwave Health

$0.14

0.015 (12.50%)

16:20
09/25/17
09/25
16:20
09/25/17
16:20
Conference/Events
Sanuwave Health to host business news update conference call »

Management provides a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PKY

Parkway

$23.00

-0.02 (-0.09%)

16:20
09/25/17
09/25
16:20
09/25/17
16:20
Hot Stocks
Parkway announces special cash dividend of $4.00 per share »

Parkway announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

CQP

Cheniere Energy Partners

$27.40

0.37 (1.37%)

16:19
09/25/17
09/25
16:19
09/25/17
16:19
Initiation
Cheniere Energy Partners initiated  »

Cheniere Energy Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RHT

Red Hat

$105.76

-0.54 (-0.51%)

16:19
09/25/17
09/25
16:19
09/25/17
16:19
Hot Stocks
Red Hat reports Q1 subscription revenue up 14% in constant currency »

Subscription revenue from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

PKY

Parkway

$23.00

-0.02 (-0.09%)

16:18
09/25/17
09/25
16:18
09/25/17
16:18
Hot Stocks
Parkway says shareholders approve merger with affiliate of CPPIB »

Parkway announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

LNG

Cheniere Energy

$44.08

0.6 (1.38%)

16:18
09/25/17
09/25
16:18
09/25/17
16:18
Initiation
Cheniere Energy initiated  »

Cheniere Energy initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RHT

Red Hat

$105.76

-0.54 (-0.51%)

16:18
09/25/17
09/25
16:18
09/25/17
16:18
Earnings
Red Hat raises FY18 adjusted EPS view to $2.77-$2.79 from $2.66-$2.70 »

Consensus $2.69. Raises…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

RHT

Red Hat

$105.76

-0.54 (-0.51%)

16:18
09/25/17
09/25
16:18
09/25/17
16:18
Earnings
Red Hat sees Q3 adjusted EPS roughly 70c, consensus 70c »

Sees Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

CRAY

Cray

$18.13

-0.475 (-2.55%)

, STX

Seagate

$33.16

-0.41 (-1.22%)

16:17
09/25/17
09/25
16:17
09/25/17
16:17
Hot Stocks
Cray finishes strategic transaction of Seagate's ClusterStor business »

Cray (CRAY) announced it…

CRAY

Cray

$18.13

-0.475 (-2.55%)

STX

Seagate

$33.16

-0.41 (-1.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNX

Synnex

$116.50

0.4 (0.34%)

16:17
09/25/17
09/25
16:17
09/25/17
16:17
Hot Stocks
SYNNEX raises quarterly dividend 20% to 30c per share »

The dividend will be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 16

    Oct

  • 17

    Oct

$NSD

NASDAQ Market Internals

16:17
09/25/17
09/25
16:17
09/25/17
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNX

Synnex

$116.50

0.4 (0.34%)

16:17
09/25/17
09/25
16:17
09/25/17
16:17
Earnings
SYNNEX sees Q4 adjusted EPS $2.63-$2.73, consensus $2.49 »

Sees Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 16

    Oct

  • 17

    Oct

RHT

Red Hat

$105.73

-0.57 (-0.54%)

16:16
09/25/17
09/25
16:16
09/25/17
16:16
Earnings
Red Hat reports Q2 adjusted EPS 77c, consensus 67c »

Reports Q2 revenue $723M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

SNX

Synnex

$116.59

0.485 (0.42%)

16:16
09/25/17
09/25
16:16
09/25/17
16:16
Hot Stocks
Breaking Hot Stocks news story on Synnex »

SYNNEX raises quarterly…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 16

    Oct

  • 17

    Oct

$NYE

NYSE Market Internals

16:16
09/25/17
09/25
16:16
09/25/17
16:16
Technical Analysis
NYSE market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IVTY

Invuity

$7.80

-0.5 (-6.02%)

16:15
09/25/17
09/25
16:15
09/25/17
16:15
Hot Stocks
Invuity announces commercial launch of PhotonBlade »

Invuit announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 16

    Nov

SNX

Synnex

$116.59

0.485 (0.42%)

16:15
09/25/17
09/25
16:15
09/25/17
16:15
Earnings
Synnex reports Q3 adjusted EPS $2.16, consensus $1.97 »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 16

    Oct

  • 17

    Oct

KDMN

Kadmon

$3.83

0.31 (8.81%)

16:13
09/25/17
09/25
16:13
09/25/17
16:13
Syndicate
Kadmon files to sell common stock and warrants »

Kadmon announced its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

PRQR

ProQR Therapeutics

$6.45

0.25 (4.03%)

16:12
09/25/17
09/25
16:12
09/25/17
16:12
Conference/Events
ProQR Therapeutics to hold a conference call »

Management discusses…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 27

    Sep

LAUR

Laureate Education

$14.10

-0.31 (-2.15%)

16:11
09/25/17
09/25
16:11
09/25/17
16:11
Hot Stocks
Breaking Hot Stocks news story on Laureate Education »

12 West Capital reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.